Raltegravir Cerebrospinal Fluid Pharmacodynamic Study in HIV-Infected Individuals
This study has been terminated.
(Did not meet enrollment goals)
University of California, San Diego
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Scott Letendre, University of California, San Diego
First received: February 9, 2011
Last updated: June 4, 2015
Last verified: June 2015
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been terminated.|
|Study Completion Date:||December 2013|
|Primary Completion Date:||June 2013 (Final data collection date for primary outcome measure)|